Report error Found 88 Enz. Inhib. hit(s) with all data for entry = 50023209
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 2.20nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 2.90nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 4.70nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 4.70nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 5.5nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 6.90nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 7.40nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 7.5nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 7.90nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 8.5nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 9.5nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 45nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 68nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 95nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 117nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 124nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 125nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 155nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 206nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 257nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 323nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 795nMAssay Description:Inhibition of Thrombin (unknown origin)More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 976nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 1.74E+3nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibition of Thrombin (unknown origin)More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetSuppressor of tumorigenicity 14 protein(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 7.35E+3nMAssay Description:Inhibition of Matriptase (unknown origin)More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 1.06E+4nMAssay Description:Inhibition of uPA (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 1.09E+4nMAssay Description:Inhibition of hepsin (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibition of hepsin (unknown origin)More data for this Ligand-Target Pair
TargetSuppressor of tumorigenicity 14 protein(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 2.38E+4nMAssay Description:Inhibition of Matriptase (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 2.47E+4nMAssay Description:Inhibition of Plasmin (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 2.81E+4nMAssay Description:Inhibition of plasma kallikrein (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 3.55E+4nMAssay Description:Inhibition of Plasmin (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 3.63E+4nMAssay Description:Inhibition of granzyme A (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 3.73E+4nMAssay Description:Inhibition of factor XIa (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 4.49E+4nMAssay Description:Inhibition of plasma kallikrein (unknown origin)More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 4.69E+4nMAssay Description:Inhibition of uPA (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 4.80E+4nMAssay Description:Inhibition of C1s (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of factor Xa (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of granzyme K (unknown origin)More data for this Ligand-Target Pair
































